AssetMemo
AssetsMechanismsCompaniesCalendarChartsWatchlistAsk AIMethodology
  • Cardiovascular & Metabolic469
  • Dermatology230
  • Gastroenterology & Hepatology177
  • Hematology45
  • Immunology176
  • Infectious Disease145
  • Nephrology130
  • Neurology478
  • Oncology1,186
  • Ophthalmology75
  • Psychiatry141
  • Rare & Genetic Diseases141
  • Respiratory162
◧AssetMemo
⌕

Evidence-graded drug-asset intelligence
◧AssetMemo
AssetsMechanismsCompaniesReadout CalendarCompare ChartsWatchlist & AlertsAsk AI
Therapeutic areas
  • Cardiovascular & Metabolic469
  • Dermatology230
  • Gastroenterology & Hepatology177
  • Hematology45
  • Immunology176
  • Infectious Disease145
  • Nephrology130
  • Neurology478
  • Oncology1,186
  • Ophthalmology75
  • Psychiatry141
  • Rare & Genetic Diseases141
  • Respiratory162
ReferenceMethodology & RubricUs vs. AI ToolsUK IBD Access GuideAbout the founder

Educational data tool. Evidence graded; securities never are.

BrowseAll assetsAll mechanismsAll companiesReadout calendarReadouts by yearResults by diseaseDelayed readoutsOpen dataCompare share pricesWhat's new
ReferenceMethodology & sourcesUs vs. the AI toolsUK IBD Access GuideAbout the founderAsk the AIReport a problem / suggest a feature

Educational research only, not investment advice. Evidence quality is graded; securities never are. · Terms · Privacy · Logos by Logo.dev

Ask

Opening the console…

Companies with late-stage biologics

166 companies hold rights to 231 biologics (antibodies, antibody fragments, multispecific antibodies, antibody-drug conjugates, other antibody scaffolds and therapeutic proteins) that are in Phase 3, Phase 2/3 or filed for approval. Sorted by the number of such drugs, then by name. Approved drugs are not counted. The full directory, with financials, is on the companies page.

BiologicsSmall moleculesCell and gene therapiesRNA and oligonucleotide drugsPeptide drugs
Late-stage biologics, by developer
CompanyTickerLate-stageDrugs (stage, indications)
Jiangsu Hengrui Pharmaceuticals60027612Adebrelimab (Phase 3, Non-Small Cell Lung Cancer, Small Cell Lung Cancer); Camrelizumab (Phase 3, Non-Small Cell Lung Cancer, Cervical Cancer, Hepatocellular Carcinoma and more); Felcorekibart (Phase 3, Atopic Dermatitis, Chronic Obstructive Pulmonary Disease, Asthma); Notiretatug rezetecan (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer, Cervical Cancer and more); Recaticimab (Phase 3, Atherosclerotic Cardiovascular Disease); Retlirafusp alfa (Phase 3, Non-Small Cell Lung Cancer, Gastric Cancer); Ruzaltatug rezetecan (Phase 3, Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer with EGFR Mutations); SHR-1819 (Phase 3, Atopic Dermatitis); SHR-1918 (Phase 3, Homozygous Familial Hypercholesterolemia); SHR-A1912 (Phase 3, Diffuse Large B-Cell Lymphoma); Trastuzumab rezetecan (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer, Ovarian Cancer and more); vunakizumab (Phase 3, Psoriatic Arthritis, Psoriasis)
AstraZenecaAZN10Anselamimab (Phase 3, AL Amyloidosis); Cliramitug (Phase 3, Transthyretin Amyloidosis with Cardiomyopathy); Gefurulimab (Phase 3, Generalized Myasthenia Gravis); Puxitatug samrotecan (Phase 3, Non-Small Cell Lung Cancer, Endometrial Cancer); Rilvegostomig (Phase 3, Non-Small Cell Lung Cancer, Hepatocellular Carcinoma, Biliary Tract Cancer and more); Sonesitatug vedotin (Phase 3, Gastric Cancer); Surovatamig (Phase 3, Systemic Lupus Erythematosus, Rheumatoid Arthritis, Follicular Lymphoma and more); Torvutatug samrotecan (Phase 3, Ovarian Cancer); tozorakimab (Phase 3, Chronic Obstructive Pulmonary Disease, Asthma); Volrustomig (Phase 3, Non-Small Cell Lung Cancer, Cervical Cancer, Head and Neck Squamous Cell Carcinoma)
PfizerPFE8afimkibart (Phase 3, Ulcerative Colitis, Crohn's Disease, Atopic Dermatitis and more); Disitamab Vedotin (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer, HER2-Positive Breast Cancer and more); Fetrastobart vedotin (Phase 3, Non-Small Cell Lung Cancer); PF-06823859 (Phase 3, Dermatomyositis); PF-08634404 (Phase 3, Non-Small Cell Lung Cancer, Colorectal Cancer, Endometrial Cancer); Sugemalimab (Phase 3, Non-Small Cell Lung Cancer); tilrekimig (Phase 3, Atopic Dermatitis, Chronic Obstructive Pulmonary Disease, Asthma); Sasanlimab (Phase 2/3, Non-Small Cell Lung Cancer)
RocheRHHBY8afimkibart (Phase 3, Ulcerative Colitis, Crohn's Disease, Atopic Dermatitis and more); astegolimab (Phase 3, Chronic Obstructive Pulmonary Disease); Cevostamab (Phase 3, Multiple Myeloma, Systemic Lupus Erythematosus); Pegozafermin (Phase 3, MASH / NASH, Severe Hypertriglyceridemia); Prasinezumab (Phase 3, Parkinson's Disease); Tambotatug pelitecan (Phase 3, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma and more); Trontinemab (Phase 3, Alzheimer's Disease); Vamikibart (Phase 3, Uveitic Macular Edema)
AbbVieABBV7ABBV-706 (Phase 3, Small Cell Lung Cancer); Etentamig (Phase 3, Multiple Myeloma, AL Amyloidosis); lutikizumab (Phase 3, Atopic Dermatitis, Rheumatoid Arthritis, Hidradenitis Suppurativa); RC148 (Phase 3, Non-Small Cell Lung Cancer); Telisotuzumab Adizutecan (Phase 3, Non-Small Cell Lung Cancer, Colorectal Cancer, Advanced Metastatic Colorectal Cancer); Budigalimab (Phase 2/3, Non-Small Cell Lung Cancer, Urothelial Carcinoma); Pivekimab Sunirine (Phase 2/3, Acute Myeloid Leukemia)
Biocad—7Acellbia (Phase 3, Rheumatoid Arthritis); BCD-264 (Phase 3, Multiple Myeloma); BCD-281 (Phase 3, Multiple Sclerosis); Divozilimab (Phase 3, Systemic Lupus Erythematosus, Multiple Sclerosis, Systemic Sclerosis); Levilimab (Phase 3, Rheumatoid Arthritis, COVID-19); netakimab (Phase 3, Psoriatic Arthritis, Psoriasis); Torutamig (Phase 3, Multiple Myeloma)
Merck & Co.MRK7Gocatamig (Phase 3, Small Cell Lung Cancer); Ifinatamab Deruxtecan (Phase 3, Non-Small Cell Lung Cancer, Metastatic Castration-Resistant Prostate Cancer, Small Cell Lung Cancer and more); Patritumab Deruxtecan (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer, Breast Cancer); Raludotatug Deruxtecan (Phase 3, Non-Small Cell Lung Cancer, Ovarian Cancer); Sacituzumab Tirumotecan (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer, Ovarian Cancer and more); tulisokibart (Phase 3, Ulcerative Colitis, Crohn's Disease, Hidradenitis Suppurativa and more); Zilovertamab vedotin (Phase 2/3, Diffuse Large B-Cell Lymphoma)
Qilu Pharmaceutical—7Iparomlimab (QL1604) (Phase 3); Iparomlimab and tuvonralimab (Phase 3, Non-Small Cell Lung Cancer, Metastatic Colorectal Cancer); QL2106 (Phase 3, Psoriasis); QL2108 (Phase 3, Atopic Dermatitis); QL2109 (Phase 3, Multiple Myeloma); QLS32015 (Phase 3, Multiple Myeloma); QLS4131 (Phase 3, Multiple Myeloma)
Shanghai Henlius Biotech26967HLX01 (Phase 3, Rheumatoid Arthritis); HLX04 (Phase 3, Non-Small Cell Lung Cancer, Colorectal Cancer); HLX04-O (Phase 3, Age-Related Macular Degeneration); HLX15 (Phase 3, Multiple Myeloma); Serplulimab (Phase 3, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Gastric Cancer); HLX43 (Phase 2/3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer); Pimurutamab (Phase 2/3, Non-Small Cell Lung Cancer)
Akeso99266Cadonilimab (Phase 3, Non-Small Cell Lung Cancer, Cervical Cancer, Hepatocellular Carcinoma); Ebdarokimab (Phase 3, Psoriasis); Ebronucimab (Phase 3, Atherosclerotic Cardiovascular Disease, Mixed Hyperlipidemia); Gumokimab (Phase 3, Psoriasis); Ivonescimab (Phase 3, Non-Small Cell Lung Cancer, Biliary Tract Cancer, Metastatic Colorectal Cancer); Manfidokimab (Phase 3, Atopic Dermatitis)
Innovent Biologics18016IBI3003 (Phase 3, Multiple Myeloma); IBI305 (Phase 3, Non-Small Cell Lung Cancer, Colorectal Cancer); IBI363 (Phase 3, Non-Small Cell Lung Cancer, Colorectal Cancer); picankibart (Phase 3, Ulcerative Colitis, Psoriasis); Sintilimab (Phase 3, Non-Small Cell Lung Cancer); Tafolecimab (Phase 3, Atherosclerotic Cardiovascular Disease)
Regeneron PharmaceuticalsREGN6Cenvacibart (Phase 3, Venous Thromboembolism); Fianlimab (Phase 3, Melanoma); Freneslerbart/mevonlerbart (Phase 3, Asthma, Allergic Conjunctivitis, Cat Allergy); mibavademab (Phase 3, Obesity, Generalized Lipodystrophy); Odronextamab (Phase 3, Systemic Lupus Erythematosus, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma and more); Pozelimab (Phase 3, Age-Related Macular Degeneration, Paroxysmal Nocturnal Hemoglobinuria, Generalized Myasthenia Gravis)
BioNTechBNTX4Beruzatatug pelitecan (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer); Elfetabart drozuntecan (Phase 3, Non-Small Cell Lung Cancer, Metastatic Castration-Resistant Prostate Cancer); Pumitamig (Phase 3, Non-Small Cell Lung Cancer, Small Cell Lung Cancer); Trastuzumab pamirtecan (Phase 3, HR+/HER2- Metastatic Breast Cancer, HER2-Positive Breast Cancer, Endometrial Cancer)
Bristol-Myers SquibbBMY4Atigotatug (Phase 3, Small Cell Lung Cancer); Izalontamab brengitecan (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer, Ovarian Cancer and more); Obexelimab (Phase 3, Systemic Lupus Erythematosus, IgG4-Related Disease); Pumitamig (Phase 3, Non-Small Cell Lung Cancer, Small Cell Lung Cancer)
Daiichi Sankyo45684Denosumab (Xgeva) (Phase 3, Non-Small Cell Lung Cancer, Multiple Myeloma, HR+/HER2- Metastatic Breast Cancer); Ifinatamab Deruxtecan (Phase 3, Non-Small Cell Lung Cancer, Metastatic Castration-Resistant Prostate Cancer, Small Cell Lung Cancer and more); Patritumab Deruxtecan (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer, Breast Cancer); Raludotatug Deruxtecan (Phase 3, Non-Small Cell Lung Cancer, Ovarian Cancer)
Keymed Biosciences21624Gamgertamig (CM336) (Phase 3, Multiple Myeloma); Lumrotatug (Phase 3, Multiple Myeloma); Ocankitug (Phase 3, Chronic Obstructive Pulmonary Disease, Asthma); stapokibart (Phase 3, Atopic Dermatitis, Chronic Obstructive Pulmonary Disease, Asthma and more)
RemeGen Co., Ltd.6883314Disitamab Vedotin (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer, HER2-Positive Breast Cancer and more); RC148 (Phase 3, Non-Small Cell Lung Cancer); RC28-E (Phase 3, Age-Related Macular Degeneration, Diabetic Macular Edema); Telitacicept (Phase 3, Rheumatoid Arthritis, IgA Nephropathy, Sjögren's Disease and more)
SanofiSNY4duvakitug (Phase 3, Ulcerative Colitis, Crohn's Disease, Hidradenitis Suppurativa); Frexalimab (Phase 3, Systemic Lupus Erythematosus, Multiple Sclerosis); lunsekimig (Phase 3, Atopic Dermatitis, Chronic Obstructive Pulmonary Disease, Asthma); Riliprubart (Phase 3, Chronic Inflammatory Demyelinating Polyneuropathy)
AmgenAMGN3Abp 234 (Phase 3, Non-Small Cell Lung Cancer); ABP 692 (Phase 3, Multiple Sclerosis); Denosumab (Xgeva) (Phase 3, Non-Small Cell Lung Cancer, Multiple Myeloma, HR+/HER2- Metastatic Breast Cancer)
Celltrion0682703CT-P44 (Phase 3, Multiple Myeloma); CT-P51 (Phase 3, Non-Small Cell Lung Cancer); CT-P53 (Phase 3, Multiple Sclerosis)
Gilead SciencesGILD3Gamgertamig (CM336) (Phase 3, Multiple Myeloma); Teropavimab (Phase 3, HIV); Zinlirvimab (Phase 3, HIV)
GlaxoSmithKlineGSK3Efimosfermin alfa (Phase 3, MASH / NASH); Felcorekibart (Phase 3, Atopic Dermatitis, Chronic Obstructive Pulmonary Disease, Asthma); Risvutatug rezetecan (Phase 3, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Esophageal Squamous Cell Carcinoma)
Johnson & JohnsonJNJ3Cetrelimab (Phase 3, Non-Small Cell Lung Cancer, Bladder Cancer); Pasritamig (Phase 3, Metastatic Castration-Resistant Prostate Cancer); Ramantamig (Phase 3, Multiple Myeloma)
Kodiak Sciences Inc.KOD3Tabirafusp alfa (Phase 3); Tabirafusp tedromer (Phase 3, Age-Related Macular Degeneration, Diabetic Macular Edema); Tarcocimab tedromer (Phase 3, Age-Related Macular Degeneration, Wet Age-Related Macular Degeneration)
Shanghai Junshi Bioscience18773JS207 (Phase 3, Non-Small Cell Lung Cancer, Hepatocellular Carcinoma, Breast Cancer); Ongericimab (Phase 3, Atherosclerotic Cardiovascular Disease); Roconkibart (Phase 3, Psoriasis)
Sichuan Baili Pharmaceutical6885063Izalontamab (Phase 3, Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Esophageal Squamous Cell Carcinoma); Izalontamab brengitecan (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer, Ovarian Cancer and more); Trastuzumab brengitecan (Phase 3, Non-Small Cell Lung Cancer, Ovarian Cancer, Colorectal Cancer and more)
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.69903Sacituzumab Tirumotecan (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer, Ovarian Cancer and more); Tagitanlimab (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer, Nasopharyngeal Carcinoma); WIN378 (Phase 2/3, Chronic Obstructive Pulmonary Disease, Asthma)
Simcere Pharmaceutical20963Endostar (Phase 3, Non-Small Cell Lung Cancer); Envafolimab (Phase 3, HIV, Non-Small Cell Lung Cancer, Chronic Hepatitis B and more); Rademikibart (Phase 3, Atopic Dermatitis, Chronic Obstructive Pulmonary Disease, Asthma)
Sinocelltech Group Ltd.6885203SCTB14 (Phase 3, Non-Small Cell Lung Cancer); SCTC21C (Phase 3, Multiple Myeloma, Systemic Lupus Erythematosus, IgA Nephropathy and more); SCTB41 (Phase 2/3, Non-Small Cell Lung Cancer)
Alphamab Oncology99662Anbenitamab repodatecan (Phase 3, HR+/HER2- Metastatic Breast Cancer, Colorectal Cancer, HER2-Positive Breast Cancer); Erfonrilimab (Phase 3, Non-Small Cell Lung Cancer)
Annexon, Inc.ANNX2tanruprubart (Phase 3, Huntington's Disease, Guillain-Barré Syndrome); Vonaprument (Phase 3, Age-Related Macular Degeneration, Geographic Atrophy)
Bio-Thera Solutions6881772BAT3306 (Phase 3, Non-Small Cell Lung Cancer); BAT5906 (Phase 3, Age-Related Macular Degeneration)
BiogenBIIB2Felzartamab (Phase 3, Multiple Myeloma, IgA Nephropathy, Primary Membranous Nephropathy); Litifilimab (Phase 3, Systemic Lupus Erythematosus)
BiohavenBHVN2BHV-1400 (Phase 3, Chronic Kidney Disease); taldefgrobep alfa (Phase 3, Obesity, Spinal Muscular Atrophy)
CSPC Pharmaceutical Group10932Anbenitamab repodatecan (Phase 3, HR+/HER2- Metastatic Breast Cancer, Colorectal Cancer, HER2-Positive Breast Cancer); Efmedaglutide alfa (Phase 3, Obesity, Type 2 Diabetes)
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.—2Enlonstobart (Phase 3, Non-Small Cell Lung Cancer, Cervical Cancer); stapokibart (Phase 3, Atopic Dermatitis, Chronic Obstructive Pulmonary Disease, Asthma and more)
DualityBio Inc.96062Elfetabart drozuntecan (Phase 3, Non-Small Cell Lung Cancer, Metastatic Castration-Resistant Prostate Cancer); Trastuzumab pamirtecan (Phase 3, HR+/HER2- Metastatic Breast Cancer, HER2-Positive Breast Cancer, Endometrial Cancer)
Eisai45232Serplulimab (Phase 3, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Gastric Cancer); Etalanetug (Phase 2/3, Alzheimer's Disease)
Eli LillyLLY2Remternetug (Phase 3, Alzheimer's Disease); Sofetabart mipitecan (Phase 3, Non-Small Cell Lung Cancer, Ovarian Cancer)
Everest Medicines (Beijing) Co., Ltd.19522Lerodalcibep (Phase 3, Atherosclerotic Cardiovascular Disease); Obinutuzumab beta (Bejescin) (Phase 3, Systemic Lupus Erythematosus, Follicular Lymphoma, Primary Membranous Nephropathy)
Genrix Bio6884432Telikibart (Phase 3, Atopic Dermatitis); Velinotamig (GR1803) (Phase 3, Multiple Myeloma)
Glenmark Pharmaceuticals Ltd.GLENMARK2Envafolimab (Phase 3, HIV, Non-Small Cell Lung Cancer, Chronic Hepatitis B and more); Trastuzumab rezetecan (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer, Ovarian Cancer and more)
Hangzhou Sumgen Biotech Co., Ltd.—2Enlonstobart (Phase 3, Non-Small Cell Lung Cancer, Cervical Cancer); Sanritatug (Phase 3, Multiple Myeloma, Systemic Lupus Erythematosus)
Hansoh Pharmaceutical Group36922HS-20137 (Phase 3, Psoriasis); Risvutatug rezetecan (Phase 3, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Esophageal Squamous Cell Carcinoma)
Huabo Biopharm Co.—2HB0017 (Phase 3, Psoriasis); Sotiburafusp alfa (Phase 3, Non-Small Cell Lung Cancer, Endometrial Cancer)
IncyteINCY2INCA033989 (Phase 3, Essential Thrombocythemia); INCA33890 (Phase 3, Non-Small Cell Lung Cancer, Colorectal Cancer)
Intas Pharmaceuticals—2HD204 (Phase 3, Non-Small Cell Lung Cancer); Serplulimab (Phase 3, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Gastric Cancer)
Laboratorio Elea Phoenix S.A.—2MB12 (Phase 3, Non-Small Cell Lung Cancer); Racotumomab (Phase 3, Non-Small Cell Lung Cancer)
Mabwell Bioscience68806227MW3711 (Phase 3, Non-Small Cell Lung Cancer); MW02 (Phase 2/3, Age-Related Macular Degeneration)
MediLink Therapeutics (Suzhou) Co., Ltd.—2Beruzatatug pelitecan (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer); Tambotatug pelitecan (Phase 3, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma and more)
MedImmune LLC—2Monalizumab (Phase 3, Non-Small Cell Lung Cancer); Oleclumab (Phase 3, Non-Small Cell Lung Cancer)
NovartisNVS2VAY736 (Phase 3, Sjögren's Disease); Zigakibart (Phase 3, Chronic Kidney Disease, IgA Nephropathy)
Novo NordiskNVO2Coramitug (Phase 3, Heart Failure); Ziltivekimab (Phase 3, Atherosclerotic Cardiovascular Disease)
Seagen—2Fetrastobart vedotin (Phase 3, Non-Small Cell Lung Cancer); Sigvotatug Vedotin (Phase 3, Non-Small Cell Lung Cancer)
Shanghai JMT-Bio—2Becotatug (Phase 3, Non-Small Cell Lung Cancer, Colorectal Cancer); Ocankitug (Phase 3, Chronic Obstructive Pulmonary Disease, Asthma)
Shenyang Sunshine Pharmaceutical—2Loncipoetin alfa (NuPIAO) (Phase 3, Chronic Kidney Disease); PF-08634404 (Phase 3, Non-Small Cell Lung Cancer, Colorectal Cancer, Endometrial Cancer)
Sunshine Guojian Pharmaceutical6883362Amdokitug (Yisaituo) (Phase 3, Psoriasis); SSGJ-611 (Phase 3, Atopic Dermatitis)
Takeda Pharmaceutical CompanyTAK2IBI363 (Phase 3, Non-Small Cell Lung Cancer, Colorectal Cancer); Mezagitamab (Phase 3, Chronic Kidney Disease, IgA Nephropathy)
TJ Biopharma Co., Ltd.—2Efmedaglutide alfa (Phase 3, Obesity, Type 2 Diabetes); Uliledlimab (Phase 2/3, Non-Small Cell Lung Cancer)
3D Medicines Inc.12441Envafolimab (Phase 3, HIV, Non-Small Cell Lung Cancer, Chronic Hepatitis B and more)
89bio—1Pegozafermin (Phase 3, MASH / NASH, Severe Hypertriglyceridemia)
AbbottABT1Serplulimab (Phase 3, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Gastric Cancer)
Accord Healthcare—1Serplulimab (Phase 3, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Gastric Cancer)
Actinium PharmaceuticalsATNM1131I-apamistamab (Phase 3, Acute Myeloid Leukemia)
Aeira Pte. Ltd.—1stapokibart (Phase 3, Atopic Dermatitis, Chronic Obstructive Pulmonary Disease, Asthma and more)
Agenus Inc.AGEN1Botensilimab (Phase 3, Non-Small Cell Lung Cancer, Colorectal Cancer)
AnaptysBioANAB1Imsidolimab (Phase 3, Psoriasis)
Ascletis Pharma16721Envafolimab (Phase 3, HIV, Non-Small Cell Lung Cancer, Chronic Hepatitis B and more)
Ashibio Inc—1Andecaliximab (Phase 2/3, Fibrodysplasia Ossificans Progressiva)
Astellas Pharma45031ASP2138 (Phase 3, Gastric Cancer)
Beijing Dongfang Biotech—1exendin-4 Fc fusion (JY09) (Phase 3, Type 2 Diabetes)
Beijing Mabworks Biotech Co., Ltd.—1Obinutuzumab beta (Bejescin) (Phase 3, Systemic Lupus Erythematosus, Follicular Lymphoma, Primary Membranous Nephropathy)
Beijing Xinkanghe Biomedical Technology Co., Ltd.—1Lecankitug (Phase 3, Psoriasis)
BeOne MedicinesONC1BGB-B2033 (Phase 3, Non-Small Cell Lung Cancer, Hepatocellular Carcinoma)
Biotest AG—1Human hepatitis B Immunoglobulin (Hepatect®CP/Zutectra®) (Phase 3)
Bluefin Biomedicine—1BFB759 (Phase 2/3, Atopic Dermatitis, Hidradenitis Suppurativa)
Boehringer Ingelheim—1Obrixtamig (Phase 3, Non-Small Cell Lung Cancer, Small Cell Lung Cancer)
Brii Biosciences21371Tobevibart (VIR-3434) (Phase 3, Chronic Hepatitis Delta)
Celldex TherapeuticsCLDX1barzolvolimab (Phase 3, Atopic Dermatitis, Chronic Spontaneous Urticaria, Chronic Inducible Urticaria)
Changchun GeneScience Pharmaceutical—1Somatropin (Jintropin) (Phase 3, Chronic Kidney Disease)
Chong Kun Dang Pharmaceutical1857501CKD-701 (Phase 3, Age-Related Macular Degeneration)
Compass TherapeuticsCMPX1tovecimig (Phase 2/3, Biliary Tract Cancer)
COMPUGEN LTDCGEN1Rilvegostomig (Phase 3, Non-Small Cell Lung Cancer, Hepatocellular Carcinoma, Biliary Tract Cancer and more)
Conjupro Biotherapeutics, Inc.—1CPO301 (Phase 3, Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Breast Cancer)
Connect BiopharmaCNTB1Rademikibart (Phase 3, Atopic Dermatitis, Chronic Obstructive Pulmonary Disease, Asthma)
Corbus PharmaceuticalsCRBP1Sutantatug envedotin (Phase 3, Cervical Cancer, Urothelial Carcinoma)
CSPC Megalith Biopharmaceutical—1Sutantatug envedotin (Phase 3, Cervical Cancer, Urothelial Carcinoma)
CStone Pharmaceuticals26161Sugemalimab (Phase 3, Non-Small Cell Lung Cancer)
Cullinan Therapeutics Inc.CGEM1Velinotamig (GR1803) (Phase 3, Multiple Myeloma)
CytoDynCYDY1Leronlimab (Phase 2/3, Alzheimer's Disease, HIV, Metastatic Colorectal Cancer)
DiaMedica TherapeuticsDMAC1Rinvecalinase alfa (Phase 2/3, Acute Ischemic Stroke)
Dr. Reddy's LaboratoriesRDY1HLX15 (Phase 3, Multiple Myeloma)
Elevar Therapeutics, Inc.—1Camrelizumab (Phase 3, Non-Small Cell Lung Cancer, Cervical Cancer, Hepatocellular Carcinoma and more)
Elpiscience (Suzhou) Biopharma, Ltd.—1Ordastobart (Phase 2/3, Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma)
Essex Bio-Technology Limited10611HLX04-O (Phase 3, Age-Related Macular Degeneration)
Ewopharma—1Sugemalimab (Phase 3, Non-Small Cell Lung Cancer)
Fosun Wanbang Pharma Group—1Roconkibart (Phase 3, Psoriasis)
GenmabGMAB1Rinatabart sesutecan (Rina-S) (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer, Ovarian Cancer and more)
GrifolsGRF1Human hepatitis B Immunoglobulin (Hepatect®CP/Zutectra®) (Phase 3)
HanAll BioPharma0094201Imeroprubart (Phase 3, Rheumatoid Arthritis, Myasthenia Gravis, Graves' Disease and more)
Hansa BiopharmaHNSA1Imlifidase (Phase 3, Chronic Kidney Disease)
Harbour BioMed21421WIN378 (Phase 2/3, Chronic Obstructive Pulmonary Disease, Asthma)
Huahui Health—1Libevitug (HH-003) (Phase 3, Chronic Hepatitis B, Chronic Hepatitis Delta)
Hubei Jumpcan Pharmaceutical6005661Ebronucimab (Phase 3, Atherosclerotic Cardiovascular Disease, Mixed Hyperlipidemia)
Immunocore Holdings plcIMCR1brenetafusp (Phase 3, Cutaneous Melanoma)
Immunovant, Inc.IMVT1Imeroprubart (Phase 3, Rheumatoid Arthritis, Myasthenia Gravis, Graves' Disease and more)
Inhibrx Biosciences, IncINBX1Ordastobart (Phase 2/3, Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma)
Innate PharmaIPH1Monalizumab (Phase 3, Non-Small Cell Lung Cancer)
Istituto Gentili S.R.L.—1Sugemalimab (Phase 3, Non-Small Cell Lung Cancer)
Jade Biosciences, Inc.JBIO1JADE101 (Phase 3, IgA Nephropathy)
JCR Pharmaceuticals45521JR-131 (Phase 3, Chronic Kidney Disease)
Jiangsu Genscend Biopharmaceutical—1GS101 (Phase 3, Atopic Dermatitis)
Kalbe Genexine Biologics—1Serplulimab (Phase 3, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Gastric Cancer)
Kissei Pharmaceutical45471JR-131 (Phase 3, Chronic Kidney Disease)
Laboratorios Stein S.A.—1Sugemalimab (Phase 3, Non-Small Cell Lung Cancer)
Lakefront Biotherapeutics NVLKFT1Gamgertamig (CM336) (Phase 3, Multiple Myeloma)
LIB Therapeutics—1Lerodalcibep (Phase 3, Atherosclerotic Cardiovascular Disease)
Livzon Pharmaceutical Group Inc.0005131Lecankitug (Phase 3, Psoriasis)
Lotus Pharmaceutical Co., Ltd.—1Serplulimab (Phase 3, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Gastric Cancer)
Luye Pharma Group21861LY01008 (Phase 3, Non-Small Cell Lung Cancer, Colorectal Cancer)
mAbxience Research S.L.—1MB12 (Phase 3, Non-Small Cell Lung Cancer)
Merck KGaAMKKGY1precemtabart tocentecan (Phase 3, Non-Small Cell Lung Cancer, Metastatic Colorectal Cancer)
Mereo BioPharmaMREO1setrusumab (Phase 3, Osteogenesis Imperfecta)
Merz Pharmaceuticals—1IncobotulinumtoxinA (Xeomin) (Phase 3, Parkinson's Disease, Migraine)
MoonLake ImmunotherapeuticsMLTX1sonelokimab (Phase 3, Psoriatic Arthritis, Psoriasis, Hidradenitis Suppurativa)
Multitude Therapeutics Inc.—1AMT-116 (Phase 2/3, Non-Small Cell Lung Cancer)
Nanogen Pharmaceutical Biotechnology—1NNG-DEPO (Phase 3, Chronic Kidney Disease)
Nektar TherapeuticsNKTR1rezpegaldesleukin (Phase 3, Atopic Dermatitis, Alopecia Areata)
Norgine—1Tobevibart (VIR-3434) (Phase 3, Chronic Hepatitis Delta)
NovaBridge BiosciencesNBP1Uliledlimab (Phase 2/3, Non-Small Cell Lung Cancer)
OncoC4, Inc.—1Gotistobart (Phase 3, Non-Small Cell Lung Cancer)
Polaris Group65501Pegargiminase (Phase 3, Acute Myeloid Leukemia, Hepatocellular Carcinoma)
Prestige Biopharma Limited9502101HD204 (Phase 3, Non-Small Cell Lung Cancer)
Prothena Biosciences LimitedPRTA1Prasinezumab (Phase 3, Parkinson's Disease)
Pyxis OncologyPYXS1MW02 (Phase 2/3, Age-Related Macular Degeneration)
Qyuns Therapeutics25091HS-20137 (Phase 3, Psoriasis)
Roivant Sciences Ltd.ROIV1Imeroprubart (Phase 3, Rheumatoid Arthritis, Myasthenia Gravis, Graves' Disease and more)
Santen Pharmaceutical Co., Ltd.45361RC28-E (Phase 3, Age-Related Macular Degeneration, Diabetic Macular Edema)
Savara Inc.SVRA1molgramostim (Phase 3, Autoimmune Pulmonary Alveolar Proteinosis)
Shandong New Time Pharmaceutical Co., Ltd.—1F182112 (Phase 3, Multiple Myeloma)
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.6001961Velinotamig (GR1803) (Phase 3, Multiple Myeloma)
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.6001961Serplulimab (Phase 3, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Gastric Cancer)
Shanghai Huaota Biopharmaceutical Co.—1HB0034 (Phase 2/3, Psoriasis)
Shanghai Yinnuo Pharmaceutical Technology—1efsubaglutide alfa (Phase 3, Obesity, Type 2 Diabetes)
Shenzhen Salubris Pharmaceuticals0022941SAL003 (Phase 3, Atherosclerotic Cardiovascular Disease)
Sino Biopharmaceutical11771TQB2934 (Phase 3, Multiple Myeloma)
STADA Arzneimittel—1Ranibizumab (Ximluci) (Phase 3, Age-Related Macular Degeneration)
Summit TherapeuticsSMMT1Ivonescimab (Phase 3, Non-Small Cell Lung Cancer, Biliary Tract Cancer, Metastatic Colorectal Cancer)
Sun Pharmaceutical IndustriesSUNPHARMA1Lerodalcibep (Phase 3, Atherosclerotic Cardiovascular Disease)
Suzhou Alphamab—1Envafolimab (Phase 3, HIV, Non-Small Cell Lung Cancer, Chronic Hepatitis B and more)
Suzhou Zelgen Biopharmaceuticals6882661Nilvanstomig (Phase 3, Non-Small Cell Lung Cancer, Hepatocellular Carcinoma)
SystImmune—1BL-M11D1 (Phase 2/3, Acute Myeloid Leukemia)
Teva Pharmaceutical IndustriesTEVA1duvakitug (Phase 3, Ulcerative Colitis, Crohn's Disease, Hidradenitis Suppurativa)
Timberlyne Therapeutics—1Lumrotatug (Phase 3, Multiple Myeloma)
Ultragenyx Pharmaceutical Inc.RARE1setrusumab (Phase 3, Osteogenesis Imperfecta)
United BioPharma—1Semzuvolimab (Phase 3, HIV)
Vanda PharmaceuticalsVNDA1Imsidolimab (Phase 3, Psoriasis)
Vertex PharmaceuticalsVRTX1Povetacicept (Phase 3, Myasthenia Gravis, IgA Nephropathy, Primary Membranous Nephropathy)
Vir BiotechnologyVIR1Tobevibart (VIR-3434) (Phase 3, Chronic Hepatitis Delta)
Vor BioVOR1Telitacicept (Phase 3, Rheumatoid Arthritis, IgA Nephropathy, Sjögren's Disease and more)
Windward Bio—1WIN378 (Phase 2/3, Chronic Obstructive Pulmonary Disease, Asthma)
Xbrane Biopharma ABXBRANE1Ranibizumab (Ximluci) (Phase 3, Age-Related Macular Degeneration)
Zenas BioPharmaZBIO1Obexelimab (Phase 3, Systemic Lupus Erythematosus, IgG4-Related Disease)
Zensun (Shanghai) Sci & Tech—1Recombinant human neuregulin-1 (rhNRG-1) (Phase 3, Heart Failure)
Zhejiang Doer Biologics—1DR10624 (Phase 3, Obesity, Severe Hypertriglyceridemia)
Zydus LifesciencesZYDUSLIFE1Botensilimab (Phase 3, Non-Small Cell Lung Cancer, Colorectal Cancer)

Stage is the furthest stage the drug has reached in any indication. Kind follows each drug's recorded modality; a drug whose modality is not recorded is left out.